NM_000130.5:c.1763-260T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000130.5(F5):c.1763-260T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.923 in 152,316 control chromosomes in the GnomAD database, including 64,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.92   (  64913   hom.,  cov: 33) 
Consequence
 F5
NM_000130.5 intron
NM_000130.5 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.138  
Publications
23 publications found 
Genes affected
 F5  (HGNC:3542):  (coagulation factor V) This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance. [provided by RefSeq, Oct 2008] 
F5 Gene-Disease associations (from GenCC):
- thrombophilia due to activated protein C resistanceInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
 - congenital factor V deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
 - East Texas bleeding disorderInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95). 
BP6
Variant 1-169544768-A-G is Benign according to our data. Variant chr1-169544768-A-G is described in ClinVar as Benign. ClinVar VariationId is 1230677.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| F5 | ENST00000367797.9  | c.1763-260T>C | intron_variant | Intron 11 of 24 | 1 | NM_000130.5 | ENSP00000356771.3 | |||
| F5 | ENST00000367796.3  | c.1763-245T>C | intron_variant | Intron 11 of 24 | 5 | ENSP00000356770.3 | 
Frequencies
GnomAD3 genomes   AF:  0.923  AC: 140448AN: 152198Hom.:  64861  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
140448
AN: 
152198
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.923  AC: 140558AN: 152316Hom.:  64913  Cov.: 33 AF XY:  0.924  AC XY: 68838AN XY: 74478 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
140558
AN: 
152316
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
68838
AN XY: 
74478
show subpopulations 
African (AFR) 
 AF: 
AC: 
36787
AN: 
41560
American (AMR) 
 AF: 
AC: 
14555
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3019
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
5182
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
4510
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
10035
AN: 
10612
Middle Eastern (MID) 
 AF: 
AC: 
251
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
63460
AN: 
68042
Other (OTH) 
 AF: 
AC: 
1956
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 553 
 1106 
 1660 
 2213 
 2766 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 910 
 1820 
 2730 
 3640 
 4550 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
3374
AN: 
3472
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.